|
1
|
Zhang B, Barekati Z, Kohler C, Radpour R,
Asadollahi R, Holzgreve W and Zhong XY: Proteomics and biomarkers
for ovarian cancer diagnosis. Ann Clin Lab Sci. 40:218–225.
2010.PubMed/NCBI
|
|
2
|
Wang JY, Sun T, Zhao XL, Zhang SW, Zhang
DF, Gu Q, Wang XH, Zhao N, Qie S and Sun BC: Functional
significance of VEGF-a in human ovarian carcinoma: Role in
vasculogenic mimicry. Cancer Biol Ther. 7:758–766. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang S, Zhang D and Sun B: Vasculogenic
mimicry: Current status and future prospects. Cancer Lett.
254:157–164. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Vartanian AA, Burova OS, Stepanova EV,
Baryshnikov AY and Lichinitser MR: Melanoma vasculogenic mimicry is
strongly related to reactive oxygen species level. Melanoma Res.
17:370–379. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Folkman J: Fundamental concepts of the
angiogenic process. Curr Mol Med. 3:643–651. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Maniotis AJ, Folberg R, Hess A, Seftor EA,
Gardner LM, Pe'er J, Trent JM, Meltzer PS and Hendrix MJ: Vascular
channel formation by human melanoma cells in vivo and in vitro:
Vasculogenic mimicry. Am J Pathol. 155:739–752. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sun W, Fan YZ, Zhang WZ and Ge CY: A pilot
histomorphology and hemodynamic of vasculogenic mimicry in
gallbladder carcinomas in vivo and in vitro. J Exp Clin Cancer Res.
30:462011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hess AR, Seftor EA, Seftor RE and Hendrix
MJ: Phosphoinositide 3-kinase regulates membrane Type 1-matrix
metalloproteinase (MMP) and MMP-2 activity during melanoma cell
vasculogenic mimicry. Cancer Res. 63:4757–4762. 2003.PubMed/NCBI
|
|
9
|
Sun B, Zhang D, Zhang S, Zhang W, Guo H
and Zhao X: Hypoxia influences vasculogenic mimicry channel
formation and tumor invasion-related protein expression in
melanoma. Cancer Lett. 249:188–197. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sood AK, Seftor EA, Fletcher MS, Gardner
LM, Heidger PM, Buller RE, Seftor RE and Hendrix MJ: Molecular
determinants of ovarian cancer plasticity. Am J Pathol.
158:1279–1288. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shirakawa K, Wakasugi H, Heike Y, Watanabe
I, Yamada S, Saito K and Konishi F: Vasculogenic mimicry and
pseudo-comedo formation in breast cancer. Int J Cancer. 99:821–828.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Guzman G, Cotler SJ, Lin AY, Maniotis AJ
and Folberg R: A pilot study of vasculogenic mimicry
immunohistochemical expression in hepatocellular carcinoma. Arch
Pathol Lab Med. 131:1776–1781. 2007.PubMed/NCBI
|
|
13
|
Sharma N, Seftor RE, Seftor EA, Gruman LM,
Heidger PM Jr, Cohen MB, Lubaroff DM and Hendrix MJ: Prostatic
tumor cell plasticity involves cooperative interactions of distinct
phenotypic subpopulations: Role in vasculogenic mimicry. Prostate.
50:189–201. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vartanian AA, Stepanova EV, Gutorov SL,
Solomko ESh, Grigorieva IN, Sokolova IN, Baryshnikov AY and
Lichinitser MR: Prognostic significance of periodic
acid-Schiff-positive patterns in clear cell renal cell carcinoma.
Can J Urol. 16:4726–4732. 2009.PubMed/NCBI
|
|
15
|
El Hallani S, Boisselier B, Peglion F,
Rousseau A, Colin C, Idbaih A, Marie Y, Mokhtari K, Thomas JL,
Eichmann A, et al: A new alternative mechanism in glioblastoma
vascularization: Tubular vasculogenic mimicry. Brain. 133:973–982.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li M, Gu Y, Zhang Z, Zhang S, Zhang D,
Saleem AF, Zhao X and Sun B: Vasculogenic mimicry: A new prognostic
sign of gastric adenocarcinoma. Pathol Oncol Res. 16:259–266. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Baeten CI, Hillen F, Pauwels P, de Bruine
AP and Baeten CG: Prognostic role of vasculogenic mimicry in
colorectal cancer. Dis Colon Rectum. 52:2028–2035. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shih IeM: Trophoblastic vasculogenic
mimicry in gestational choriocarcinoma. Mod Pathol. 24:646–652.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sood AK, Fletcher MS, Zahn CM, Gruman LM,
Coffin JE, Seftor EA and Hendrix MJ: The clinical significance of
tumor cell-lined vasculature in ovarian carcinoma: Implications for
anti-vasculogenic therapy. Cancer Biol Ther. 1:661–664. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zygmunt M, Herr F, Keller-Schoenwetter S,
Kunzi-Rapp K, Münstedt K, Rao CV, Lang U and Preissner KT:
Characterization of human chorionic gonadotropin as a novel
angiogenic factor. J Clin Endocrinol Metab. 87:5290–5296. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Toth P, Li X, Rao CV, Lincoln SR,
Sanfilippo JS, Spinnato JA II and Yussman MA: Expression of
functional human chorionic gonadotropin/human luteinizing hormone
receptor gene in human uterine arteries. J Clin Endocrinol Metab.
79:307–315. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wulff C, Dickson SE, Duncan WC and Fraser
HM: Angiogenesis in the human corpus luteum: Simulated early
pregnancy by HCG treatment is associated with both angiogenesis and
vessel stabilization. Hum Reprod. 16:2515–2524. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Berndt S, Perrier D'Hauterive S, Blacher
S, Péqueux C, Lorquet S, Munaut C, Applanat M, Hervé MA, Lamandé N,
Corvol P, et al: Angiogenic activity of human chorionic
gonadotropin through LH receptor activation on endothelial and
epithelial cells of the endometrium. FASEB J. 20:2630–2632. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Michel RM, Aguilar JL and Arrieta O: Human
chorionic gonadotropin as an angiogenic factor in breast cancer
during pregnancy. Med Hypotheses. 68:1035–1040. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Szajnik M, Nowak-Markwitz E, Szczepański
MJ and Spaczyński M: Assessment of expression of luteinizing
hormone (LH)/human chorionic gonadotropin (hCG) receptor (LH/hCGR)
and hCG protein in ovarian cancer tissues. Ginekol Pol. 78:939–943.
2007.(In Polish). PubMed/NCBI
|
|
26
|
Muller CY and Cole LA: The quagmire of hCG
and hCG testing in gynecologic oncology. Gynecol Oncol.
112:663–672. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lempiäinen A, Stenman UH, Blomqvist C and
Hotakainen K: Free beta-subunit of human chorionic gonadotropin in
serum is a diagnostically sensitive marker of seminomatous
testicular cancer. Clin Chem. 54:1840–1843. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Iles RK, Delves PJ and Butler SA: Does hCG
or hCGβ play a role in cancer cell biology? Mol Cell Endocrinol.
329:62–70. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Daniel KD, Kim GY, Vassiliou CC,
Jalali-Yazdi F, Langer R and Cima MJ: Multi-reservoir device for
detecting a soluble cancer biomarker. Lab Chip. 7:1288–1293. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jankowska AG, Andrusiewicz M, Fischer N
and Warchol PJ: Expression of hCG and GnRHs and their receptors in
endometrial carcinoma and hyperplasia. Int J Gynecol Cancer.
20:92–101. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Su M, Wei W, Xu X, Wang X, Chen C, Su L
and Zhang Y: Role of hCG in vasculogenic mimicry in OVCAR-3 ovarian
cancer cell line. Int J Gynecol Cancer. 21:1366–1374. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kavak S, Ayaz L and Emre M: Effects of
rosiglitazone with insulin combination therapy on oxidative stress
and lipid profile in left ventricular muscles of diabetic rats. Exp
Diabetes Res. 2012:9056832012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Newton PT, Staines KA, Spevak L, Boskey
AL, Teixeira CC, Macrae VE, Canfield AE and Farquharson C:
Chondrogenic ATDC5 cells: An optimised model for rapid and
physiological matrix mineralisation. Int J Mol Med. 30:1187–1193.
2012.PubMed/NCBI
|
|
34
|
Scimeca M, Orlandi A, Terrenato I,
Bischetti S and Bonanno E: Assessment of metal contaminants in
non-small cell lung cancer by EDX microanalysis. Eur J Histochem.
58:24032014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Brouillet S, Hoffmann P, Chauvet S,
Salomon A, Chamboredon S, Sergent F, Benharouga M, Feige JJ and
Alfaidy N: Revisiting the role of hCG: new regulation of the
angiogenic factor EG-VEGF and its receptors. Cell Mol Life Sci.
69:1537–50. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hamada AL, Nakabayashi K, Sato A, Kiyoshi
K, Takamatsu Y, Laoag-Fernandez JB, Ohara N and Maruo T:
Transfection of antisense chorionic gonadotropin beta gene into
choriocarcinoma cells suppresses the cell proliferation and induces
apoptosis. J Clin Endocrinol Metab. 90:4873–4879. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bo M and Boime I: Identification of the
transcriptionally active genes of the chorionic gonadotropin beta
gene cluster in vivo. J Biol Chem. 267:3179–3184. 1992.PubMed/NCBI
|
|
38
|
Talmadge K, Boorstein WR, Vamvakopoulos
NC, Gething MJ and Fiddes JC: Only three of the seven human
chorionic gonadotropin beta subunit genes can be expressed in the
placenta. Nucleic Acids Res. 12:8415–8436. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Meng XL, Rennert OM and Chan WY: Human
chorionic gonadotropin induces neuronal differentiation of PC12
cells through activation of stably expressed
lutropin/choriogonadotropin receptor. Endocrinology. 148:5865–5873.
2007. View Article : Google Scholar : PubMed/NCBI
|
